Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.
作者： Paul Anderson , James Louie , Anna Lau , Michael Broder , None
DOI: 10.1007/S11926-005-0002-2
关键词:
摘要:
springer.com
sci-hub.se 参考文章(28)
Jerry M. Greene, Dorothy A. Johnson, Larry G. Anderson, Robert A. Yood, Robert W. Simms, Guidelines for the Management of Rheumatoid Arthritis ,(2002)
P H Wooley, J Dutcher, S Gillis, M B Widmer, Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. Journal of Immunology. ,vol. 151, pp. 6602- 6607 ,(1993)
J R Kalden, H M Lorenz, N Schwerdtner, C Antoni, R Repp, J Woody, T Valerius, B Manger, M Grünke, H Nüsslein, In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short-term cellular and molecular effects Journal of Immunology. ,vol. 156, pp. 1646- 1653 ,(1996)
Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, Charles A. Birbara, Leah A. Teoh, Steven A. Fischkoff, Elliot K. Chartash, Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis & Rheumatism. ,vol. 48, pp. 35- 45 ,(2003) , 10.1002/ART.10697
Grace Newsome, Guidelines for the Management of Rheumatoid Arthritis 2002 Update Journal of the American Academy of Nurse Practitioners. ,vol. 14, pp. 432- 437 ,(2002) , 10.1111/J.1745-7599.2002.TB00072.X
Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S. Smolen, Diana Davis, John D. MacFarlane, Christian Antoni, Burkhard Leeb, Michael J. Elliott, James N. Woody, Thomas F. Schaible, Marc Feldmann, Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 41, pp. 1552- 1563 ,(1998) , 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W
Filip Baert, Maja Noman, Severine Vermeire, Gert Van Assche, Geert D' Haens, An Carbonez, Paul Rutgeerts, Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. The New England Journal of Medicine. ,vol. 348, pp. 601- 608 ,(2003) , 10.1056/NEJMOA020888
Urs Christen, Rana Thuerkauf, Randall Stevens, Werner Lesslauer, Immune response to a recombinant human TNFR55-IgG1 fusion protein: auto-antibodies in rheumatoid arthritis (RA) and multiple sclerosis (MS) patients have neither neutralizing nor agonist activities Human Immunology. ,vol. 60, pp. 774- 790 ,(1999) , 10.1016/S0198-8859(99)00068-3
Andries Zijlstra, Jacqueline E Testa, James P Quigley, Targeting the proteome/epitome, implementation of subtractive immunization. Biochemical and Biophysical Research Communications. ,vol. 303, pp. 733- 744 ,(2003) , 10.1016/S0006-291X(03)00357-7
B Scallon, Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions Cytokine. ,vol. 7, pp. 251- 259 ,(1995) , 10.1006/CYTO.1995.0029